The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Long-term effects of sevelamer hydrochloride on the calcium × phosphate product and lipid profile of haemodialysis patients*
Abstract
BACKGROUND: Short-term studies have suggested that sevelamer hydrochloride, a non-aluminium- and non-calcium-containing hydrogel, is an effective phosphate binder in haemodialysis patients, and may produce favourable changes in the lipid profile. METHODS: To determine the long-term effectiveness of sevelamer hydrochloride, we performed an open-label clinical trial in 192 adult patients with end-stage renal disease on haemodialysis. Drug-related changes in the concentrations of serum phosphorus, calcium, calcium x phosphate product, parathyroid hormone, and low- and high-density lipoprotein cholesterol concentrations were the major outcomes of interest. RESULTS: Treatment with sevelamer was associated with a mean change in serum phosphorus of -0.71+/-0.77 mmol/l, serum calcium of 0. 08+/-0.22 mmol/l, and calcium x phosphate product of -1.46+/-1.78 mmol/l (P<0.0001 for all comparisons). There were no significant overall treatment-related changes in parathyroid hormone. Serum levels of LDL cholesterol decreased by 0.81+/-0.75 mmol/l (mean -30%, P<0.0001) and HDL cholesterol increased by a mean of 0.15+/-0.29 mmol/l (mean +18%, P<0.0001). Drug-related adverse events were infrequent and most were of mild intensity. CONCLUSION: Sevelamer is a safe and effective phosphate binder that leads to significant improvements in the calcium x phosphate product and lipid profile of haemodialysis patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Block, G., Hulbert-Shearon, T., Levin, N., & Port, F. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v31.pm9531176 · Cited by 2,354
Lowrie, E. G., & Lew, N. L. (1990) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)70364-5 · Cited by 1,976
Poor Long-Term Survival after Acute Myocardial Infarction among Patients on Long-Term Dialysis
Herzog, C. A., Ma, J. Z., & Collins, A. J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809173391203 · Cited by 885
Slatopolsky, E., Finch, J., Denda, M., Ritter, C., Zhong, M., Dusso, A., MacDonald, P. N., & Brown, A. J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118701 · Cited by 511
Self-citationRao, D. S., Shih, M.-S., & Mohini, R. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301213280304 · Cited by 390
Calcium Carbonate as a Phosphate Binder in Patients with Chronic Renal Failure Undergoing Dialysis
Slatopolsky, E., Weerts, C., Lopez-Hilker, S., Norwood, K., Zink, M., Windus, D., & Delmez, J. (1986) · New England Journal of Medicine · doi:10.1056/nejm198607173150304 · Cited by 379
Self-citationC-reactive protein as an outcome predictor for maintenance hemodialysis patients
Owen, W. F. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00032.x · Cited by 378
Bleyer, A. J., Burke, S. K., Dillon, M., Garrett, B., Kant, K. S., Lynch, D., Rahman, S. N., Schoenfeld, P., Teitelbaum, I., Zeig, S., et al. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70221-0 · Cited by 274
Self-citationCardiovascular Risk Factors in Chronic Renal Failure and Hemodialysis Populations
Ma, K. W., Greene, E. L., & Raij, L. (1992) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80827-4 · Cited by 269
Chertow, G. M., Burke, S. K., Lazarus, J. M., Stenzel, K. H., Wombolt, D. G., Goldberg, D., Bonventre, J. V., & Slatopolsky, E. (1997) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(97)90009-3 · Cited by 244
Self-citationFractures and vertebral bone mineral density in patients with renal osteodystrophy.
Piraino, B., Chen, T. C., Cooperstein, L. A., Segre, G. V., & Puschett, J. B. (1988) · PubMed · Cited by 153
Effects of excess PTH on nonclassical target organs
Bro, S., & Ølgaard, K. (1997) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(97)90484-4 · Cited by 120
Subacute infusion of physiological doses of parathyroid hormone raises blood pressure in humans
Fliser, D., Franek, E., FODE, P., Stefański, A., Schmitt, C. P., Lyons, M., & Ritz, E. (1997) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/12.5.933 · Cited by 94
Serum Lipids Predict Cardiac Death in Diabetic Patients on Maintenance Hemodialysis
Tschöpe, W., Koch, M., Thomas, B., & Ritz, E. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000187353 · Cited by 89
Bone Disease and Aluminum: Pathogenic Considerations
Goodman, W. G. (1985) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(85)80089-5 · Cited by 63
Etiology of Hypercalcemia in Hemodialysis Patients on Calcium Carbonate Therapy
Meric, F., Yap, P., & BIA, M. J. (1990) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80059-x · Cited by 61
Mölgaard, J., von Schenck, H., & OLSSON, A. G. (1989) · European Journal of Clinical Pharmacology · doi:10.1007/bf00558069 · Cited by 36
Probstfield, J. L., Statland, B. E., Gorman, L., et al. (1983) · Metabolism · doi:10.1016/0026-0495(83)90113-0 · Cited by 8
Cited by
Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients
Chertow, G. M., Burke, S. K., Raggi, P., & for the Treat to Goal Working Group (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00434.x · Cited by 1,462
Self-citationBlock, G. A., & Port, F. K. (2000) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(00)70064-3 · Cited by 594
Vascular calcification in chronic kidney disease
Goodman, W. G., London, G., Amann, K., Block, G. A., Giachelli, C., Hruska, K. A., Ketteler, M., Levin, A., Massy, Z., McCarron, D. A., et al. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2003.12.005 · Cited by 417
Qunibi, W., Moustafa, M., Muenz, L. R., He, D. Y., Kessler, P. D., Diaz-Buxo, J. A., & Budoff, M. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.02.298 · Cited by 311
Metabolic Bone Disease in Chronic Kidney Disease
Martin, K. J., & González, E. A. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006070771 · Cited by 288
Metadata
- Authors
- Chertow, G. M., Burke, S. K., Dillon, M. A., & Slatopolsky, E.
- Venue
- Nephrology Dialysis Transplantation
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-12-01
- Volume
- 14
- Issue
- 12
- Pages
- 2907-2914
- ISSN
- 0931-0509 (ISSN-L)
- 1460-2385
- OpenAlex
- W2110693651
- Cited by
- 296
- References
- 19
- FWCI
- 13.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.